Compare DUO & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DUO | VVOS |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 19.4M |
| IPO Year | 2019 | 2020 |
| Metric | DUO | VVOS |
|---|---|---|
| Price | $1.99 | $2.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 110.0K | ★ 121.3K |
| Earning Date | 11-19-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,189,313.00 | $17,317,000.00 |
| Revenue This Year | N/A | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.30 | 18.76 |
| 52 Week Low | $1.24 | $1.98 |
| 52 Week High | $13.57 | $7.95 |
| Indicator | DUO | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 38.11 |
| Support Level | $1.86 | $1.98 |
| Resistance Level | $2.44 | $2.28 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 37.18 | 25.71 |
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.